Stay updated on Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Sign up to get notified when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    NIH grant/contract attributions for 2023 and 2014 were added to the study record, and the revision tag was updated to v3.6.6, reflecting a metadata update.
    Difference
    0.2%
    Check dated 2026-08-29T20:00:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.4 to v3.6.5, signaling a small update to the page's version or content.
    Difference
    0.0%
    Check dated 2026-08-08T23:19:14.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The revision of the page was updated from v3.6.3 to v3.6.4, indicating a small patch to the document's revision metadata.
    Difference
    0.0%
    Check dated 2026-07-25T12:49:54.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page’s revision indicator was updated to v3.6.3, signaling a version update; this does not modify the study details themselves.
    Difference
    0.0%
    Check dated 2026-07-03T23:55:39.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.0 to v3.6.2, signaling a new version in the revision history rather than a modification to the study content.
    Difference
    0.0%
    Check dated 2026-06-26T22:27:34.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The page now shows recruitment as no longer looking for participants, and new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) were added. A formatting change updates the Intervention label from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-12T10:53:58.000Z thumbnail image

Stay in the know with updates to Acalabrutinib vs Ibrutinib in CLL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Acalabrutinib vs Ibrutinib in CLL Clinical Trial page.